Primoris Services Corporation Announces Solar Award
DALLAS, June 01, 2020 (GLOBE NEWSWIRE) — Primoris Services Corporation (NASDAQ Global Select: PRIM) (“Primoris” or “Company”) today announced the […]
MUSCLE MAKER GRILL TO OPEN FOUR LOCATIONS AT NORTHERN VIRGINIA COMMUNITY COLLEGE
Healthier for you brand signs lease for four NOVA community college locationsBurleson, TX, June 01, 2020 (GLOBE NEWSWIRE) — Muscle […]
TSX News -
Colabor Group Inc. Announces the Extension of Its Credit Facilities and Subordinated Debt
BOUCHERVILLE, Quebec, June 01, 2020 (GLOBE NEWSWIRE) — Colabor Group Inc. (“Colabor”) (TSX: GCL) announces the extension of the term […]
TSX News -
Bombardier Concludes Sale of the CRJ Series Regional Jet Program to Mitsubishi Heavy Industries
All amounts in this press release are in U.S. dollars unless otherwise indicated.Through this sale, MHI acquires the maintenance, support, […]
TSX News -
Rogers and Jays Care Foundation Step Up to the Plate for Food Banks Canada, with 8 Million Meals at Rogers Centre
TORONTO, June 01, 2020 (GLOBE NEWSWIRE) — The home of the Blue Jays is set to become the temporary home […]
Auxly Announces Record Net Revenues of Approximately $10 Million in Q1 2020
TORONTO, June 01, 2020 (GLOBE NEWSWIRE) — Auxly Cannabis Group Inc. (TSX.V – XLY) (OTCQX: CBWTF) (“Auxly” or the “Company“) […]
Aileron Therapeutics Announces Positive Interim Results from Phase 1b/2 Clinical Trial of ALRN-6924 for the Prevention of Topotecan-induced Toxicities During Treatment for Small Cell Lung Cancer
– – –Observed a protective effect against severe chemotherapy-induced anemia and thrombocytopenia across all dose levels– – –Management to host […]
LHC Group to present at two virtual investor conferences in June
LAFAYETTE, La., June 01, 2020 (GLOBE NEWSWIRE) — LHC Group, Inc. (NASDAQ: LHCG) announced today that the Company is presenting […]
Baudax Bio Secures $50 Million Credit Facility
MALVERN, Pa., June 01, 2020 (GLOBE NEWSWIRE) — Baudax Bio, Inc. (NASDAQ:BXRX), a pharmaceutical company focused on therapeutics for acute […]
Altimmune Launches Clinical Trial of T-COVIDTM, an Investigational Intranasal Immune Modulator for the Treatment of Patients with Early COVID-19
Clearance of IND application received from the U.S. FDAPlanned Phase 1/2 outpatient clinical trial will focus on patients with early […]
